Cargando…

Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544

[Image: see text] We report a detailed investigation into the application of visible light-mediated photocatalysis to a challenging bond construction in a complex pharmaceutical target. The optimized reaction allowed the direct coupling of N-methylmorpholine with an unfunctionalized pyridazine in go...

Descripción completa

Detalles Bibliográficos
Autores principales: Douglas, James J., Cole, Kevin P., Stephenson, Corey R. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260666/
https://www.ncbi.nlm.nih.gov/pubmed/25356724
http://dx.doi.org/10.1021/jo502288q
_version_ 1782348203661721600
author Douglas, James J.
Cole, Kevin P.
Stephenson, Corey R. J.
author_facet Douglas, James J.
Cole, Kevin P.
Stephenson, Corey R. J.
author_sort Douglas, James J.
collection PubMed
description [Image: see text] We report a detailed investigation into the application of visible light-mediated photocatalysis to a challenging bond construction in a complex pharmaceutical target. The optimized reaction allowed the direct coupling of N-methylmorpholine with an unfunctionalized pyridazine in good yield and selectivity, and with high purity of the product isolated via crystallization. The reaction also facilitated the expedient synthesis of a range of analogues via the use of other commercially available N-methyl substituted tertiary amines, and therefore it represents an attractive tool for medicinal chemistry. Furthermore, a number of other interesting photoredox reactions were discovered during the course of this investigation, such as a formal methylation reaction via C–N bond cleavage, functionalization of C–H bonds alpha to amides, and a visible light-mediated iminium ion reduction.
format Online
Article
Text
id pubmed-4260666
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-42606662015-10-30 Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544 Douglas, James J. Cole, Kevin P. Stephenson, Corey R. J. J Org Chem [Image: see text] We report a detailed investigation into the application of visible light-mediated photocatalysis to a challenging bond construction in a complex pharmaceutical target. The optimized reaction allowed the direct coupling of N-methylmorpholine with an unfunctionalized pyridazine in good yield and selectivity, and with high purity of the product isolated via crystallization. The reaction also facilitated the expedient synthesis of a range of analogues via the use of other commercially available N-methyl substituted tertiary amines, and therefore it represents an attractive tool for medicinal chemistry. Furthermore, a number of other interesting photoredox reactions were discovered during the course of this investigation, such as a formal methylation reaction via C–N bond cleavage, functionalization of C–H bonds alpha to amides, and a visible light-mediated iminium ion reduction. American Chemical Society 2014-10-30 2014-12-05 /pmc/articles/PMC4260666/ /pubmed/25356724 http://dx.doi.org/10.1021/jo502288q Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Douglas, James J.
Cole, Kevin P.
Stephenson, Corey R. J.
Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544
title Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544
title_full Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544
title_fullStr Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544
title_full_unstemmed Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544
title_short Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544
title_sort photoredox catalysis in a complex pharmaceutical setting: toward the preparation of jak2 inhibitor ly2784544
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260666/
https://www.ncbi.nlm.nih.gov/pubmed/25356724
http://dx.doi.org/10.1021/jo502288q
work_keys_str_mv AT douglasjamesj photoredoxcatalysisinacomplexpharmaceuticalsettingtowardthepreparationofjak2inhibitorly2784544
AT colekevinp photoredoxcatalysisinacomplexpharmaceuticalsettingtowardthepreparationofjak2inhibitorly2784544
AT stephensoncoreyrj photoredoxcatalysisinacomplexpharmaceuticalsettingtowardthepreparationofjak2inhibitorly2784544